WHOOP Adds Women’s Health Blood Biomarker Panel to Its Lab Testing Lineup
The new panel includes 11 female-specific biomarkers covering hormonal transitions, thyroid function, and nutrient levels.
Latest Articles
Editor's Top Picks
Deep Learning Pathology Models Caught ‘Cheating,’ Study Finds
A University of Warwick study finds AI cancer detection models may rely on statistical correlations rather than true biomarker signals, raising concerns about reliability in clinical pathology applications.
Be the First to Know What’s Next in the Lab
Every week, we dig into the biggest shifts, breakthroughs, and tech transforming clinical diagnostics. Straightforward, insightful, and always relevant.Critical Resources
Diagnostic Innovations
Baylor Genetics Adds Optical Genome Mapping and Long-Read Sequencing to Whole Genome Sequencing Test
Baylor Genetics has added optical genome mapping and long-read sequencing to its whole genome sequencing test, expanding STR analysis, enabling FMR1 methylation detection, and improving structural variant interpretation.
Equipment & Supply Spotlight
Quest Diagnostics Launches AI Tool to Help Patients Interpret Lab Results
The AI companion analyzes up to five years of personal lab data within the company's patient portal to explain test results and identify health trends.
News, Know-How & Standards
Disease Detection & Understanding
Hepion Pharmaceuticals Licenses ctRNA Biomarker Assay for Liver Cancer Detection
Hepion Pharmaceuticals has licensed a circulating tumor RNA assay from Cirna Diagnostics for early detection of hepatocellular carcinoma in high-risk patients, expanding its liquid biopsy portfolio for liver cancer.
